Baroreflex sensitivity and the blood pressure response to β-blockade

Journal of Human Hypertension

Volumn 13, Issue 3, 1999, Pages 185-190

  Chen, X ^b   Hassan, M O ^b   Jones, J V ^b   Sleight, P ^b   Floras, J S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Ambulatory blood pressure; Baroreflex sensitivity for heart rate; Blood pressure variability; Exercise; Hypertension; adrenoceptor blockade

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PHENYLEPHRINE; PINDOLOL; PROPRANOLOL;

ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BICYCLE; BLOOD PRESSURE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; HEART DILATATION; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033020985     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000786     Document Type: Article

References (30)

1. Floras JS, Jones JV, Hassan MO, Sleight P. Effects of acute and chronic β-adrenoceptor blockade on baroreflex sensitivity in humans. J Autonomic Nervous System 1988; 25: 87-94.
2. Vesalainen RK et al. Vagal cardiac activity in essential hypertension: the effects of metoprolol and ramipril. Am J Hypertens 1998; 11: 649-658.
3. Parati G et al. β-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. Hypertension 1994; 23[part 2]: 992-996.
4. Lucini D, Pagani M, Malliani A. Improved baroreflex control of the heart rate with chronic beta-adrenergic blockade in mild hypertension. J Hypertens 1993; 11 (Suppl 5): S156-S157.
5. Simon G, Kiowski W, Julius S. Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol 1997; 22: 293-298.
6. Watson RDS, Stallard TJ, Littler WA. Effects of β-adrenoceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man. Clin Sci 1979; 57: 241-247.
7. Floras JS et al. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11: 273-281.
8. Floras JS et al. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens 1988; 6: 525-535.
9. Floras JS, Hassan MO, Jones JV, Sleight P. Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity. J Am Coll Cardiol 1986; 6: 186-195.
10. Parati G et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93-98.
11. Verdecchia P et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
12. Mancia G et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril. Circulation 1997; 95: 1460-1470.
13. Frattola A et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
14. Stott FD. The Oxford portable blood pressure transducer. In: Clement DL, ed. Blood pressure variability. MTP Press: Lancaster, UK, 1979, pp 55-60.
15. Ebert TJ. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 1985; 7: 602-606.
16. Giannattasio G et al. Investigation of reflexes from volume and baroreceptors during converting enzyme inhibition in humans. Am Heart J 1989; 117: 740-745.
17. Egan BM et al. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens 1993; 11: 1113-1120.
18. Tomiyana H et al. Effects of an ACE inhibitor and a calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension. Am J Hypertens 1998; 11: 682-689.
19. McLeay RAB, Stallard TJ, Watson RDS, Littler WA. The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation 1983; 67: 1084-1090.
20. Young MA, Watson RDS, Littler WA. Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin Sci 1984; 66: 233-235.
21. Young MA, Watson RDS, Littler WA. Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man. J Hypertens 1985; 3: 481-483.
22. Kailasam MT et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995; 26: 143-149.
23. La Rovere et al, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478-484.
24. Yusuf S et al. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovasc Dis 1985; 27: 335-371.
25. Lechat P et al. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98: 1184-1191.
26. Ichikawa M et al. Differential modulation of baroreceptor sensitivity by long-term antihypertensive treatment. Hypertension 1995; 26: 425-431.
27. Wallin BG, Sundlof G, Stromgren E, Aberg H. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension 1984; 6: 557-562.
28. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1971; 29: 437-445.
29. Kumagai K et al. Comparison of early and late start of antihypertensive agents and baroreceptor reflexes. Hypertension 1996; 27: 209-218.
30. Poller U et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29: 187-193.